These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 2579040

  • 1. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity.
    Hendricks RL, Sugar J.
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):201-7. PubMed ID: 2579040
    [Abstract] [Full Text] [Related]

  • 2. Lysis of herpes simplex virus (HSV) infected targets. IV. HSV-induced change in the effector population.
    Hendricks RL, Sugar J.
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):208-13. PubMed ID: 3972502
    [Abstract] [Full Text] [Related]

  • 3. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C, Lopez C.
    J Immunol; 1986 May 01; 136(9):3473-80. PubMed ID: 2420891
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
    Muñoz A, Carrasco L, Fresno M.
    J Immunol; 1983 Aug 01; 131(2):783-7. PubMed ID: 6190939
    [Abstract] [Full Text] [Related]

  • 5. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
    Fitzgerald-Bocarsly P, Feldman M, Curl S, Schnell J, Denny T.
    J Immunol; 1989 Aug 15; 143(4):1318-26. PubMed ID: 2526183
    [Abstract] [Full Text] [Related]

  • 6. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR, Foster CS.
    Invest Ophthalmol Vis Sci; 1990 Nov 15; 31(11):2224-9. PubMed ID: 1700771
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR, Asuncion M, Fons M, Norton JD, Albrecht T, Klimpel KD, Stein MD.
    J Clin Lab Immunol; 1989 May 15; 29(1):1-7. PubMed ID: 2560794
    [Abstract] [Full Text] [Related]

  • 8. Role of interferon in natural kill of HSV-1-infected fibroblasts.
    Fitzgerald PA, von Wussow P, Lopez C.
    J Immunol; 1982 Aug 15; 129(2):819-23. PubMed ID: 6177785
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA, Evans R, Kirkpatrick D, Lopez C.
    J Immunol; 1983 Apr 15; 130(4):1663-7. PubMed ID: 6601135
    [Abstract] [Full Text] [Related]

  • 10. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Jul 15; 133(1):422-7. PubMed ID: 6609990
    [Abstract] [Full Text] [Related]

  • 11. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
    Paya CV, Schoon RA, Leibson PJ.
    J Immunol; 1990 Jun 01; 144(11):4370-5. PubMed ID: 2160501
    [Abstract] [Full Text] [Related]

  • 12. Lysis of herpes simplex virus (HSV) infected targets. I. A comparison of the activity of lymphocytes from patients with HSV recurrences at different anatomical sites.
    Hendricks RL, Sugar J.
    Curr Eye Res; 1984 Mar 01; 3(3):473-80. PubMed ID: 6321105
    [Abstract] [Full Text] [Related]

  • 13. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 14. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA, Glorioso JC, Schwartz SA.
    J Immunol; 1983 Oct 01; 131(4):1849-53. PubMed ID: 6194217
    [Abstract] [Full Text] [Related]

  • 15. Defective NK cell activity following thermal injury.
    Klimpel GR, Herndon DN, Fons M, Albrecht T, Asuncion MT, Chin R, Stein MD.
    Clin Exp Immunol; 1986 Nov 01; 66(2):384-92. PubMed ID: 3493101
    [Abstract] [Full Text] [Related]

  • 16. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Nov 01; 133(5):2736-42. PubMed ID: 6207243
    [Abstract] [Full Text] [Related]

  • 17. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
    Santoli D, Trinchieri G, Koprowski H.
    J Immunol; 1978 Aug 01; 121(2):532-8. PubMed ID: 150448
    [Abstract] [Full Text] [Related]

  • 18. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA, Mendelsohn M, Lopez C.
    J Immunol; 1985 Apr 01; 134(4):2666-72. PubMed ID: 2982949
    [Abstract] [Full Text] [Related]

  • 19. Role of natural killer T (NKT) cells lacking interleukin (IL)-4 producing abilities on the CC-chemokine ligand 2-associated herpes simplex virus type 1 infection in human severe combined immunodeficiency (SCID) mouse chimeras.
    Fujita K, Sandford AP, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F.
    Burns; 2005 Mar 01; 31(2):145-52. PubMed ID: 15683684
    [Abstract] [Full Text] [Related]

  • 20. Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts.
    Oh SH, Bandyopadhyay S, Miller DS, Starr SE.
    J Immunol; 1987 Oct 15; 139(8):2799-802. PubMed ID: 2821120
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.